Hybrid Nonviral Nanocarriers Enable Functional Neural Modulation

Area of Science:

• Neuroscience
• Biotechnology
• Nanomedicine

Background:

• Extracellular vesicles (EVs) from neurons facilitate intercellular communication via cargo transfer.
• Existing delivery systems like liposomes and native EVs have limitations in specificity, efficiency, and toxicity.
• Targeted delivery of nucleic acids to the central nervous system (CNS) remains a challenge.

Purpose of the Study:

• To engineer hybrid nanoparticles combining astrocyte-derived exosomes and synthetic liposomes for enhanced CNS delivery.
• To overcome limitations of conventional liposomes and native EVs for gene transfer.
• To validate the efficacy and safety of the hybrid nanoparticles in vivo.

Main Methods:

• Fusion of astrocyte-derived exosomes with RNA-loaded synthetic liposomes to create sub-100 nm hybrid nanoparticles.
• Tuning nanoparticle surface properties (mildly cationic) for efficient neuronal gene transfer.
• In vivo validation in transgenic mice using Cre recombinase mRNA and channelrhodopsin-2 expression.

Main Results:

• Developed hybrid nanoparticles with efficient gene transfer capabilities to neurons.
• Demonstrated no disruption of neuronal membrane integrity or significant cytotoxicity.
• Successfully induced gene expression in specific brain regions (motor cortex, ventral tegmental area) in vivo.
• Observed behavioral changes in mice following optogenetic stimulation, confirming functional delivery.

Conclusions:

• The engineered hybrid nanoparticles represent a novel and effective platform for CNS gene delivery.
• This approach overcomes key limitations of existing delivery systems, offering improved specificity and efficiency.
• The validated in vivo efficacy suggests potential applications in neurological research and therapeutic interventions.